В этой теме нет ответов

[Perrywalton]

Armotraz plays a major role in improving breast cancer treatment, especially for postmenopausal women with hormone receptor-positive tumors. As an aromatase inhibitor, Armotraz effectively inhibits the production of estrogen, a hormone that promotes the growth of hormone receptor-positive breast tumors. Armotraz lowers tumor growth and the risk of recurrence by decreasing estrogen levels in the body. This medicine is frequently used as adjuvant therapy after surgery or as the first-line treatment for advanced breast cancer. While Armotraz may induce side effects such as hot flashes and joint discomfort, its shown efficacy in improving outcomes and prolonging survival highlights its value in breast cancer management, giving patients a significant tool in their fight against the illness.